|
Health
|
Essential health care industry news & intel to start your day.
|
April 11, 2021
|
|
|
We’ve redesigned the newsletter to improve the experience for you, and we have more changes coming soon to help keep you informed about the week ahead. Please let us know what you think of the new design.
|
|
|
Week in Review
COVID-19 vaccines
- It’s “plausible” that the COVID-19 vaccine developed by the University of Oxford and AstraZeneca PLC is tied to rare but potentially fatal blood clots, European regulators said, which could further complicate the rollout of the shot globally.
- Production of Moderna Inc.’s COVID-19 vaccine will nearly double after the company reached an agreement with contract manufacturer Catalent Inc. to increase vaccine output to about 400 vials per minute at its Bloomington, Ind., plant, people familiar with the decision said.
- Walgreens Boots Alliance Inc. said it will change its scheduling system for the Pfizer Inc.-BioNTech SE COVID-19 vaccine after federal health officials discovered the pharmacy chain was automatically booking people’s first and second dose four weeks apart, rather than the recommended three weeks, for scheduling ease.
COVID-19 response
- President Joe Biden said all U.S. adults should be made eligible for a COVID-19 vaccine by April 19, nearly two weeks earlier than the original May 1 deadline.
- A more contagious coronavirus variant first identified in the United Kingdom is now the primary source of new infections in the United States, said Dr. Rochelle Walensky, director of the Centers for Disease Control and Prevention.
- A rheumatoid arthritis drug from Eli Lilly and Co. and Incyte Corp. failed to keep COVID-19 patients from progressing to ventilation in a late-stage study, the companies said. U.S. regulators had previously authorized the drug, called baricitinib, for emergency use in combination with remdesivir for COVID-19 patients who need supplemental oxygen.
Health and Human Services
- About 528,000 people have signed up for health insurance through the Affordable Care Act during the Biden administration’s special enrollment period, according to the Centers for Medicare and Medicaid Services. Officials expect sign-ups to continue rising in the coming months, given millions of people are newly eligible for increased premium subsidies under the $1.9 trillion COVID-19 relief bill.
- The CDC declared racism a “serious public health threat” and added a section to its website to highlight racism and health. Walensky said the CDC would take steps to address the issue, including using COVID-19 funding to address health disparities and invest in groups disproportionately affected by the pandemic.
- The state of Florida sued U.S. health authorities to force them to allow cruise ships to resume voyages out of the United States after more than a year of dormancy, with Republican Gov. Ron DeSantis saying he doesn’t think the federal government “has the right to mothball a major industry for over a year.”
|
|
|
|
What’s Ahead
- The Senate and the House are both in session.
- The House Appropriations Committee will hold a hearing at 10 a.m. Thursday on the 2022 fiscal year budget request from the Department of Health and Human Services.
- UnitedHealth Inc. will report quarterly earnings Thursday.
|
|
|
|
|
Events Calendar (All Times Local)
Tuesday, April 13 |
The Washington Post Live event: Vaccines & Variants with Dr. Céline Gounder and Dr. Julie Morita Read More |
11:00 am |
Stat News event: A conversation on the latest in neuroscience and CNS drug development Read More |
1:00 pm |
Senate Committee on Commerce, Science, and Transportation hearing: The State of Travel and Tourism During COVID Read More |
3:00 pm |
Wednesday, April 14 |
National Institutes of Health Meeting of the Advisory Committee on Research on Women’s Health Read More |
9:30 am |
Senate Committee on Homeland Security & Governmental Affairs hearing: Preparedness for COVID-19: The Initial Pandemic Response and Lessons Learned Read More |
10:00 am |
House Energy and Commerce Committee hearing: An Epidemic within a Pandemic: Understanding Substance Use and Misuse in America Read More |
10:30 am |
Senate Committee on Indian Affairs hearing: Examining the COVID-19 Response in Native Communities: Native Health Systems One Year Later Read More |
2:30 pm |
U.S. Congress Joint Economic Committee hearing: Vaccinations and the Economic Recovery Read More |
2:30 pm |
|
|
|
|
|
|
Morning Consult Health Top Reads
1) People flocked to Florida and Texas for a lower cost of living during the pandemic. Some were shocked when their healthcare got way more expensive.
Kimberly Leonard, Insider
2) Most of the Public Favors Digital Vaccine Passports — but Only if They’re Not Mandatory
Gaby Galvin, Morning Consult
3) 1 in 3 Covid-19 patients are diagnosed with a neuropsychiatric condition in the next six months, large study finds
Elizabeth Cooney, Stat News
4) Big Hospitals vs. Big Pharma: Which industry is most to blame for soaring health care costs?
Geoff Colvin, Fortune
5) As Variants Have Spread, Progress Against the Virus in U.S. Has Stalled
Lauren Leatherby, The New York Times
6) The Billionaire Who Controls Your Medical Records
Katie Jennings, Forbes
7) Biden moves deadline for all US adults to be eligible for Covid vaccine to April 19
Kaitlan Collins et al., CNN
8) There’s no point person in Biden’s HHS for its $187 billion Covid-19 fund for health care providers
Rachel Cohrs, Stat News
9) U.S. Taps Johnson & Johnson to Run Troubled Vaccine Plant
Sheryl Gay Stolberg, The New York Times
10) Not-for-profit hospitals spend less on charity care than for-profit, public providers
Matti Gellman, Modern Healthcare
|
|
|
|
|
|